Plasma-derived versus recombinant hepatitis B vaccines

Lancet. 1989 Feb 25;1(8635):451. doi: 10.1016/s0140-6736(89)90057-3.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Clinical Trials as Topic
  • Female
  • Hepatitis B / immunology*
  • Hepatitis B Antibodies / analysis
  • Hepatitis B Vaccines
  • Humans
  • Immunization Schedule
  • Male
  • Random Allocation
  • Vaccines / immunology*
  • Vaccines, Synthetic / immunology*
  • Viral Hepatitis Vaccines / immunology*

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Vaccines
  • Vaccines
  • Vaccines, Synthetic
  • Viral Hepatitis Vaccines